ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
25 June 2018Americas

Eli Lilly secures patent win against Dr Reddy’s

A US court handed victory to Eli Lilly late last week after finding that a drug for which Dr Reddy’s is seeking approval would infringe a patent covering cancer treatment Alimta (pemetrexed for injection).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
3 May 2017   A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.
Americas
12 December 2018   Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.
Americas
13 August 2019   The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

More on this story

Americas
3 May 2017   A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.
Americas
12 December 2018   Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.
Americas
13 August 2019   The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

More on this story

Americas
3 May 2017   A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.
Americas
12 December 2018   Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.
Americas
13 August 2019   The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.